HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) Announce Alignment with FDA on Pediatric Study Plan for NRX-100 (ketamine)
by /u/Front-Page_News in /r/nasdaq
Upvotes: 1
Favorite this post:
Mark as read:
Your rating:
Add this post to a custom list